RECRUITING

Effectiveness of Phenazopyridine for Pain Following Urodynamics

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.

Official Title

Effectiveness of Phenazopyridine for Pain Following Urodynamics

Quick Facts

Study Start:2024-12-17

Study Completion:2025-07-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06577493

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* ability to provide informed consent * ability to complete visual analog scale * requiring urodynamic testing * 18 years of age or older * must be able to read and write in English or Spanish	* allergy to phenazopyridine * a urinary tract infection in the prior 2 weeks * women who did not undergo urodynamic testing * patient less than 18 years old * patients with known (noted in patient chart and verbally asked) severe renal insufficiency with GFR \<50 mL/min, * patients with known (noted in patient chart and verbally asked) severe hepatitis * patients with known (noted in patient chart and verbally asked) G6PD deficiency * history of fibromyalgia * history of interstitial cystitis * non English or Spanish speaking

Inclusion Criteria

Exclusion Criteria

* ability to provide informed consent
* ability to complete visual analog scale
* requiring urodynamic testing
* 18 years of age or older
* must be able to read and write in English or Spanish

* allergy to phenazopyridine
* a urinary tract infection in the prior 2 weeks
* women who did not undergo urodynamic testing
* patient less than 18 years old
* patients with known (noted in patient chart and verbally asked) severe renal insufficiency with GFR \<50 mL/min,
* patients with known (noted in patient chart and verbally asked) severe hepatitis
* patients with known (noted in patient chart and verbally asked) G6PD deficiency
* history of fibromyalgia
* history of interstitial cystitis
* non English or Spanish speaking

Contacts and Locations

Study Contact

Elizabeth Wilkinson, MD

CONTACT

8139745638

wilkinsone@usf.edu

Principal Investigator

Elizabeth A Wilkinson, MD

PRINCIPAL_INVESTIGATOR

University of South Florida

Study Locations (Sites)

University of South Florida South Tampa Center

Tampa, Florida, 33606

United States

Collaborators and Investigators

Sponsor: University of South Florida

Elizabeth A Wilkinson, MD, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-17

Study Completion Date2025-07-01

Study Record Updates

Study Start Date2024-12-17

Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

Pain After Urodynamic Testing